INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.420
-0.070 (-4.70%)
At close: Jun 26, 2026, 4:00 PM EDT
1.487
+0.067 (4.73%)
After-hours: Jun 26, 2026, 7:24 PM EDT
INmune Bio Stock Forecast
INMB's stock price has decreased by -80.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for INmune Bio stock have an average target of 8.00, with a low estimate of 7.00 and a high estimate of 9.00. The average target predicts an increase of 463.38% from the current stock price of 1.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for INmune Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +463.38% | Jun 24, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $7 | Buy | Maintains | $7 | +392.96% | Apr 6, 2026 |
| Lucid Capital | Lucid Capital | Buy Upgrades $2 → $9 | Buy | Upgrades | $2 → $9 | +533.80% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
n/a
from 50.00K
Decreased by -100.00%
Revenue Next Year
6.36M
EPS This Year
-0.60
from -1.19
EPS Next Year
-0.53
from -0.60
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 15.2M | |
| Avg | n/a | 6.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.44 | -0.50 | |
| Avg | -0.60 | -0.53 | |
| Low | -0.82 | -0.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.